Global Lenalidomide Drug Market Size, Share, and COVID-19 Impact Analysis, By Type (5mg, 10mg, 15mg, 25mg), By Application (Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), and Others), By End User (Hospitals, Cancer Treatment Centers, Research Institute), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare
RELEASE DATE Jun 2024
REPORT ID SI4573
PAGES 220
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction

1.1. Objectives of the Study

1.2. Market Definition

1.3. Research Scope

       2. Research Methodology and Assumptions

       3. Executive Summary

       4. Premium Insights

4.1. Porter’s Five Forces Analysis

4.2. Value Chain Analysis

4.3. Top Investment Pockets

4.3.1. Market Attractiveness Analysis By Type

4.3.2. Market Attractiveness Analysis By Application

4.3.3. Market Attractiveness Analysis By End Users

4.3.4. Market Attractiveness Analysis By Region

4.4. Industry Trends

        5. Market Dynamics

5.1. Market Evaluation

5.2. Drivers

5.2.1. Lenalidomide-treated multiple myeloma, major cell lymphoma, follicular lymphoma, marginal zone lymphoma, and anemia

5.3. Restraints

5.3.1. Increased by the aging population that is occurring globally

5.4. Opportunities

5.4.1. Exploring combination therapies and testing lenalidomide in other hematological cancers could significantly expand the eligible patient pool

5.5. Challenges

5.5.1.  The patent expiry of branded drugs is posing significant challenges for the growth  of the lenalidomide drug market

    6. Global Lenalidomide Drug Market Analysis and Projection, By Type

6.1. Segment Overview

6.2. 5mg capsules

6.3. 10mg capsules

6.4. 15mg capsules

6.5. 25mg capsules

 

       7. Global Lenalidomide Drug Market Analysis and Projection, By Application

7.1. Segment Overview

7.2. Multiple Myeloma (MM)

7.3. Myelodysplastic Syndromes (MDS)

7.4. Others

 

     8. Global Lenalidomide Drug Market Analysis and Projection, By End Users

8.1. Segment Overview

8.2. Hospitals

8.3. Cancer Treatment Centers

8.4. Research Institute

     9. Global Lenalidomide Drug Market Analysis and Projection, By Regional Analysis

 9.1. Segment Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.2.3. Mexico

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. U.K.

9.3.4. Italy

9.3.5. Spain

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.5. South America

9.5.1. Brazil

9.6. Middle East and Africa

9.6.1. UAE

9.6.2. South Africa

      10. Global Lenalidomide Drug Market -Competitive Landscape

10.1. Overview

10.2. Market Share of Key Players in the Lenalidomide Drug Market

10.2.1. Global Company Market Share

10.2.2. North America Company Market Share

10.2.3. Europe Company Market Share

10.2.4. APAC Company Market Share

10.3. Competitive Situations and Trends

10.3.1. Coverage Launches and Developments

10.3.2. Partnerships, Collaborations, and Agreements

10.3.3. Mergers & Acquisitions

10.3.4. Expansions

        11. Company Profiles

11.1. Celgene Corporation (Acquired by Bristol Myers Squibb)

11.1.1. Business Overview

11.1.2. Company Snapshot

11.1.3. Company Market Share Analysis

11.1.4. Company Coverage Portfolio

11.1.5. Recent Developments

11.1.6. SWOT Analysis

11.2. Natco Pharma Limited

11.2.1. Business Overview

11.2.2. Company Snapshot

11.2.3. Company Market Share Analysis

11.2.4. Company Coverage Portfolio

11.2.5. Recent Developments

11.2.6. SWOT Analysis

11.3. Mylan N.V.

11.3.1. Business Overview

11.3.2. Company Snapshot

11.3.3. Company Market Share Analysis

11.3.4. Company Coverage Portfolio

11.3.5. Recent Developments

11.3.6. SWOT Analysis

11.4. Dr. Reddy's Laboratories Ltd.

11.4.1. Business Overview

11.4.2. Company Snapshot

11.4.3. Company Market Share Analysis

11.4.4. Company Coverage Portfolio

11.4.5. Recent Developments

11.4.6. SWOT Analysis

11.5. Cipla Ltd. 

11.5.1. Business Overview

11.5.2. Company Snapshot

11.5.3. Company Market Share Analysis

11.5.4. Company Coverage Portfolio

11.5.5. Recent Developments

11.5.6. SWOT Analysis

11.6. Sun Pharmaceutical Industries Ltd.

11.6.1. Business Overview

11.6.2. Company Snapshot

11.6.3. Company Market Share Analysis

11.6.4. Company Coverage Portfolio

11.6.5. Recent Developments

11.6.6. SWOT Analysis

11.7. LUPIN

11.7.1. Business Overview

11.7.2. Company Snapshot

11.7.3. Company Market Share Analysis

11.7.4. Company Coverage Portfolio

11.7.5. Recent Developments

11.7.6. SWOT Analysis

11.8. Glenmark Pharmaceuticals

11.8.1. Business Overview

11.8.2. Company Snapshot

11.8.3. Company Market Share Analysis

11.8.4. Company Coverage Portfolio

11.8.5. Recent Developments

11.8.6. SWOT Analysis

11.9. Accord Healthcare

11.9.1. Business Overview

11.9.2. Company Snapshot

11.9.3. Company Market Share Analysis

11.9.4. Company Coverage Portfolio

11.9.5. Recent Developments

11.9.6. SWOT Analysis

11.10. Strides Pharma Science Limited

11.10.1. Business Overview

11.10.2. Company Snapshot

11.10.3. Company Market Share Analysis

11.10.4. Company Coverage Portfolio

11.10.5. Recent Developments

11.10.6. SWOT Analysis

11.11. Hetero Drugs Limited

11.11.1. Business Overview

11.11.2. Company Snapshot

11.11.3. Company Market Share Analysis

11.11.4. Company Coverage Portfolio

11.11.5. Recent Developments

11.11.6. SWOT Analysis

11.12. Teva Pharmaceutical Industries Ltd.

11.12.1. Business Overview

11.12.2. Company Snapshot

11.12.3. Company Market Share Analysis

11.12.4. Company Coverage Portfolio

11.12.5. Recent Developments

11.12.6. SWOT Analysis

11.13. Alkem Laboratories

11.13.1. Business Overview

11.13.2. Company Snapshot

11.13.3. Company Market Share Analysis

11.13.4. Company Coverage Portfolio

11.13.5. Recent Developments

11.13.6. SWOT Analysis

11.14. Aurobindo Pharma Ltd.

11.14.1. Business Overview

11.14.2. Company Snapshot

11.14.3. Company Market Share Analysis

11.14.4. Company Coverage Portfolio

11.14.5. Recent Developments

11.14.6. SWOT Analysis

11.15. Novartis International AG.

11.15.1. Business Overview

11.15.2. Company Snapshot

11.15.3. Company Market Share Analysis

11.15.4. Company Coverage Portfolio

11.15.5. Recent Developments

11.15.6. SWOT Analysis

11.16. Others

11.16.1. Business Overview

11.16.2. Company Snapshot

11.16.3. Company Market Share Analysis

11.16.4. Company Coverage Portfolio

11.16.5. Recent Developments

11.16.6. SWOT Analysis

 

List of Table

  1. Global Lenalidomide Drug Market, By Type, 2023-2033(USD Billion)
  2. Global 5mg capsules, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  3. Global 10mg capsules, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  4. Global 15mg capsules, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  5. Global 25mg capsules, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  6. Global Lenalidomide Drug Market, By Application, 2023-2033(USD Billion)
  7. Global Multiple Myeloma (MM), Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  8. Global Myelodysplastic Syndromes (MDS), Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  9. Global Others, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  10. Global Lenalidomide Drug Market, By End Users, 2023-2033(USD Billion)
  11. Global Hospitals, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  12. Global Cancer Treatment Centers, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  13. Global Research Institute, Lenalidomide Drug Market, By Region, 2023-2033(USD Billion)
  14. North America Lenalidomide Drug Market, By Type, 2023-2033(USD Billion)
  15. North America Lenalidomide Drug Market, By Application, 2023-2033(USD Billion)
  16. North America Lenalidomide Drug Market, By End Users, 2023-2033(USD Billion)
  17. U.S.  Lenalidomide Drug Market, By Type, 2023-2033(USD Billion)
  18. U.S.  Lenalidomide Drug Market, By Application, 2023-2033(USD Billion)
  19. U.S.  Lenalidomide Drug Market, By End Users, 2023-2033(USD Billion)
  20. Canada Lenalidomide Drug Market, By Type, 2023-2033(USD Billion)
  21. Canada Lenalidomide Drug Market, By Application, 2023-2033(USD Billion)
  22. Canada Lenalidomide Drug Market, By End Users, 2023-2033(USD Billion)
  23. Mexico Lenalidomide Drug Market, By Type, 2023-2033(USD Billion)
  24. Mexico Lenalidomide Drug Market, By Application, 2023-2033(USD Billion)
  25. Mexico Lenalidomide Drug Market, By End Users, 2023-2033(USD Billion)
  26. Europe Lenalidomide Drug Market, By Type, 2023-2033(USD Billion)
  27. Europe Lenalidomide Drug Market, By Application, 2023-2033(USD Billion)
  28. Europe Lenalidomide Drug Market, By End Users, 2023-2033(USD Billion)
  29. Germany Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  30. Germany Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  31. Germany Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  32. France Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  33. France Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  34. France Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  35. U.K.  Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  36. U.K.  Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  37. U.K.  Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  38. Italy Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  39. Italy Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  40. Italy Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  41. Spain Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  42. Spain Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  43. Spain Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  44. Asia Pacific Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  45. Asia Pacific Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  46. Asia Pacific Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  47. Japan Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  48. Japan Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  49. Japan Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  50. China Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  51. China Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  52. China Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  53. India Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  54. India Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  55. India Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  56. South America Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  57. South America Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  58. South America Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  59. Brazil Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  60. Brazil Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  61. Brazil Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  62. The Middle East and Africa Lenalidomide Drug Market By Type, 2023-2033(USD   Billion)
  63. The Middle East and Africa Lenalidomide Drug Market By Application, 2023-2033(USD   Billion)
  64. The Middle East and Africa Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  65. UAE Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  66. UAE Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  67. UAE Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)
  68. South Africa Lenalidomide Drug Market By Type, 2023-2033(USD Billion)
  69. South Africa Lenalidomide Drug Market By Application, 2023-2033(USD Billion)
  70. South Africa Lenalidomide Drug Market By End Users, 2023-2033(USD Billion)

 

List of Figures 

  1. Global Lenalidomide Drug Market Segmentation
  2. Lenalidomide Drug Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Lenalidomide Drug Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers: Lenalidomide Drug Market
  20. Lenalidomide Drug Market Segmentation, By Type
  21. Lenalidomide Drug Market For 5mg capsules, By Region, 2023-2033 ($ Billion)
  22. Lenalidomide Drug Market For 10mg capsules, By Region, 2023-2033 ($ Billion)
  23. Lenalidomide Drug Market For 15mg capsules, By Region, 2023-2033 ($ Billion)
  24. Lenalidomide Drug Market For 25mg capsules, By Region, 2023-2033 ($ Billion)
  25. Lenalidomide Drug Market Segmentation, By Application
  26.  Lenalidomide Drug Market For Multiple Myeloma (MM), By Region, 2023-2033 ($ Billion)
  27.  Lenalidomide Drug Market For Myelodysplastic Syndromes (MDS), By Region, 2023-2033 ($ Billion)
  28. Lenalidomide Drug Market For Others, By Region, 2023-2033 ($ Billion)
  29. Lenalidomide Drug Market Segmentation, By End Users
  30. Lenalidomide Drug Market For Hospitals, By Region, 2023-2033 ($ Billion)
  31. Lenalidomide Drug Market For Cancer Treatment Centers, By Region, 2023-2033 ($ Billion)
  32. Lenalidomide Drug Market For Research Institute, By Region, 2023-2033 ($ Billion)
  33. Celgene Corporation (Acquired by Bristol Myers Squibb): Net Sales, 2023-2033 ($ Billion)
  34. Celgene Corporation (Acquired by Bristol Myers Squibb): Revenue Share, By Segment, 2023 (%)
  35. Celgene Corporation (Acquired by Bristol Myers Squibb): Revenue Share, By Region, 2023 (%)
  36. Natco Pharma Limited: Net Sales, 2023-2033 ($ Billion)
  37. Natco Pharma Limited: Revenue Share, By Segment, 2023 (%)
  38. Natco Pharma Limited: Revenue Share, By Region, 2023 (%)
  39. Mylan N.V.: Net Sales, 2023-2033 ($ Billion)
  40. Mylan N.V.: Revenue Share, By Segment, 2023 (%)
  41. Mylan N.V.: Revenue Share, By Region, 2023 (%)
  42. Dr. Reddy's Laboratories Ltd.: Net Sales, 2023-2033 ($ Billion)
  43. Dr. Reddy's Laboratories Ltd.: Revenue Share, By Segment, 2023 (%)
  44. Dr. Reddy's Laboratories Ltd.: Revenue Share, By Region, 2023 (%)
  45. Cipla Ltd.: Net Sales, 2023-2033 ($ Billion)
  46. Cipla Ltd.: Revenue Share, By Segment, 2023 (%)
  47. Cipla Ltd.: Revenue Share, By Region, 2023 (%)
  48. Sun Pharmaceutical Industries Ltd.: Net Sales, 2023-2033 ($ Billion)
  49. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2023 (%)
  50. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2023 (%)
  51. LUPIN: Net Sales, 2023-2033 ($ Billion)
  52. LUPIN: Revenue Share, By Segment, 2023 (%)
  53. LUPIN: Revenue Share, By Region, 2023 (%)
  54. Glenmark Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  55. Glenmark Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  56. Glenmark Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  57. Accord Healthcare: Net Sales, 2023-2033 ($ Billion)
  58. Accord Healthcare: Revenue Share, By Segment, 2023 (%)
  59. Accord Healthcare: Revenue Share, By Region, 2023 (%)
  60. Strides Pharma Science Limited: Net Sales, 2023-2033 ($ Billion)
  61. Strides Pharma Science Limited: Revenue Share, By Segment, 2023 (%)
  62. Strides Pharma Science Limited: Revenue Share, By Region, 2023 (%)
  63. Hetero Drugs Limited: Net Sales, 2023-2033 ($ Billion)
  64. Hetero Drugs Limited: Revenue Share, By Segment, 2023 (%)
  65. Hetero Drugs Limited: Revenue Share, By Region, 2023 (%)
  66. Teva Pharmaceutical Industries Ltd.: Net Sales, 2023-2033 ($ Billion)
  67. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2023 (%)
  68. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2023 (%)
  69. Alkem Laboratories: Net Sales, 2023-2033 ($ Billion)
  70. Alkem Laboratories: Revenue Share, By Segment, 2023 (%)
  71. Alkem Laboratories: Revenue Share, By Region, 2023 (%)
  72. Aurobindo Pharma Ltd.: Net Sales, 2023-2033 ($ Billion)
  73. Aurobindo Pharma Ltd.: Revenue Share, By Segment, 2023 (%)
  74. Aurobindo Pharma Ltd.: Revenue Share, By Region, 2023 (%)
  75. Novartis International AG.: Net Sales, 2023-2033 ($ Billion)
  76. Novartis International AG.: Revenue Share, By Segment, 2023 (%)
  77. Novartis International AG.: Revenue Share, By Region, 2023 (%)
  78. Others: Net Sales, 2023-2033 ($ Billion)
  79. Others: Revenue Share, By Segment, 2023 (%)
  80. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:220
Countries covered:17
Companies covered::20
Forecast CAGR:5.69%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies